COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 2263: Articles 22621-22630  | Next

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in Covid-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Cruz, L. R., Baladron, I., Rittoles, A., Diaz, P. A., Valenzuela, C., Santana, R., Vazquez, M. M., Garcia, A., Chacon, D., Thompson, D., Perera, G., Gonzalez, A., Reyes, R., Torres, L., Perez, J., Vazquez, D. M., Lemus, G., Rosales, M., Ramon, A. C., Perez, G. V., Guillen, G., Muzio, V., Perera, Y., Perea, S., ATENEA-Co-300 group
10.1101/2020.09.03.20187112 — Posted: 2020-09-15
Are we there yet? An adaptive SIR model for continuous estimation of COVID-19 infection rate and reproduction number in the United States
Shapiro, M. B., Karim, F., Muscioni, G., Augustine, A. S.
10.1101/2020.09.13.20193896 — Posted: 2020-09-15
Containment to outbreak tipping points in COVID-19
Arim, M., Herrera-Esposito, D., Bermolen, P., Cabana, A., Fariello, M. I., Lima, M., Romero, H.
10.1101/2020.09.14.20194159 — Posted: 2020-09-15
A Comparative Study to Find a Suitable Model for an Improved Real-Time Monitoring of The Interventions to Contain COVID-19 Outbreak in The High Incidence States of India
G.S, A., Sharma, A., Sharma, A.
10.1101/2020.09.14.20190447 — Posted: 2020-09-15
LOW BIRTH WEIGHT AS A RISK FACTOR FOR SEVERE COVID-19 IN ADULTS
Crispi, F., Crovetto, F., Larroya, M., Camacho, M., Sibila, O., Badia, J. R., Lopez, M., Vellve, K., Garcia, F., Trilla, A., Faner, R., Blanco, I., Borras, R., Agusti, A., Gratacos, E.
10.1101/2020.09.14.20193920 — Posted: 2020-09-15 Discussion: Offsite
Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Meta-Analysis Approach
Beckman, M. F., Igba, C. K., Mougeot, F. B., Mougeot, J.-L.
10.1101/2020.09.14.20192609 — Posted: 2020-09-15 Discussion: Offsite
COVID-19 Mortality in Cancer Patients: A Report from a Tertiary Cancer Centre in India
Mehta, A., Vasudevan, S., Parkash, A., Sharma, A., Vashist, T., Krishna, V.
10.1101/2020.09.14.20194092 — Posted: 2020-09-15
Phylogenomic reveals multiple introductions and early spread of SARS-CoV-2 into Peru
Juscamayta Lopez, E., Tarazona, D., Valdivia Guerrero, F., Rojas Serrano, N., Carhuaricra, D., Maturrano Hernandez, L., Gavilan Chavez, R.
10.1101/2020.09.14.296814 — Posted: 2020-09-14
Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines
He, L., Lin, X., Wang, Y., Abraham, C., Sou, C., Ngo, T., Zhang, Y., Wilson, I. A., Zhu, J.
10.1101/2020.09.14.296715 — Posted: 2020-09-14
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
Pedrosa, C. d. S. G., Goto-Silva, L., Gomes, I. C., Souza, L. R. Q., Vitória, G., Ornelas, I. M., Karmirian, K., Mendes, M. A., Salerno, J. A., Puig-Pijuan, T., Veríssimo, C., Temerozo, J. R., Furtado, D. R., Borges, H. L., Souza, T. M. L., Guimarães, M. Z. P., Rehen, S.
10.1101/2020.09.11.293951 — Posted: 2020-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).